These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 478803)

  • 21. Effect of prostaglandin inhibition on the renal vascular response to ionic and non-ionic contrast media in the dog.
    Lund G; Einzig S; Rysavy J; Salomonowitz E; Castaneda-Zuniga W; Amplatz K
    Acta Radiol Diagn (Stockh); 1984; 25(5):407-10. PubMed ID: 6507135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of radiographic contrast agents on bleeding time and platelet aggregation.
    Verdirame JD; Davis JW; Phillips PE
    Clin Cardiol; 1984 Jan; 7(1):31-4. PubMed ID: 6705286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast and electrolyte dynamics of the intravenous pyelogram. II. Disparities in serum and urine concentrations of meglumine and anion.
    Lasser EC; Lang JH; Hamblin AE; Rosen L
    Invest Radiol; 1975; 10(4):307-13. PubMed ID: 1184320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particulate contrast media for computed tomographic scanning of the liver.
    Violante MR; Dean PB; Fischer HW; Mahoney JA
    Invest Radiol; 1980; 15(6 Suppl):S171-5. PubMed ID: 7203919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast media for computer tomography of the liver.
    Wegener OH; Mützel W; Souchon R
    Acta Radiol Diagn (Stockh); 1980; 21(2A):239-47. PubMed ID: 7424559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal excretion mechanism of a nonionic contrast agent.
    Golman K; Wilk I
    Invest Radiol; 1979; 14(3):224-7. PubMed ID: 468494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the effect of iodine containing opaque media on erythrocyte acetylcholinesterase (author's transl)].
    Vielhauer E; Schulze B; Trunk P
    Arzneimittelforschung; 1977 Jul; 27(7):1469-71. PubMed ID: 578475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CT-tomometrie. Part 2: Diagnostic--contrast media of iodine (author's transl)].
    Kirschner H; Burmester U; Stringaris K
    Strahlentherapie; 1977 Sep; 153(9):616-9. PubMed ID: 906048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotics and ERCP: in vitro activity of aminoglycosides when added to iodinated contrast agents.
    Jendrzejewski JW; McAnally T; Jones SR; Katon RM
    Gastroenterology; 1980 Apr; 78(4):745-8. PubMed ID: 7353761
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein binding of metrizamide and the effect on various enzymes.
    Salvesen S; Frey K
    Acta Radiol Suppl; 1973; 335():247-52. PubMed ID: 4534560
    [No Abstract]   [Full Text] [Related]  

  • 31. Biliary excretion of urographic contrast media (iothalamate, diatrizoate, P 286 and metrizamide).
    Owman T; Olin T
    Ann Radiol (Paris); 1978; 21(4-5):309-14. PubMed ID: 718088
    [No Abstract]   [Full Text] [Related]  

  • 32. A quantitative in vivo comparison of six contrast agents by digital subtraction angiography.
    Burbank FH; Brody WR; Hall A; Keyes G
    Invest Radiol; 1982; 17(6):610-6. PubMed ID: 6759455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of computed tomography and nephrography in quantitative comparison of urographic contrast agents.
    Wilson BC; Evill CA
    Radiology; 1981 Jul; 140(1):127-34. PubMed ID: 7244214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Varying results of different procedures for determining the FT4 concentration before and after the administration of contrast media].
    Beyer HK; Schulze B
    Nuklearmedizin; 1984 Aug; 23(4):183-7. PubMed ID: 6483629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of isotonic contrast agents on spinal reflexes in the cat.
    Hilal SK; Dauth GW; Burger LC; Gilman S
    Radiology; 1977 Jan; 122(1):149-55. PubMed ID: 830325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiphasic renal CT: comparison of renal mass enhancement during the corticomedullary and nephrographic phases.
    Birnbaum BA; Jacobs JE; Ramchandani P
    Radiology; 1996 Sep; 200(3):753-8. PubMed ID: 8756927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic potential of contrast enhancement pharmacokinetics.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1978; 13(6):533-40. PubMed ID: 755032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative uptake of low- and high-osmolality contrast media in CT of brain tumors.
    Fike JR; Cann CE; Norman D; Turrel JM; LeCouteur RA; Pflugfeld CM; Borcich JK
    Invest Radiol; 1984; 19(6 Suppl):S312-6. PubMed ID: 6096290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of contrast medium dose and image acquisition timing on ureteral opacification in the normal dog as assessed by computed tomography.
    Barthez PY; Begon D; Delisle F
    Vet Radiol Ultrasound; 1998; 39(6):524-7. PubMed ID: 9845189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knee arthrography: effects of various contrast media and epinephrine on synovial fluid.
    Corbetti F; Malatesta V; Camposampiero A; Mazzi A; Punzi L; Angelini F; Vigo M; Todesco S
    Radiology; 1986 Oct; 161(1):195-8. PubMed ID: 3763866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.